Stocks › GMED
GLOBUS MEDICAL INC
GMED·NYSE·
United States·USD
United States·USD$76.43
-0.14 (-0.18%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
GMED
GLOBUS MEDICAL INC · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
GMEDS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of GMED by members of U.S. Congress · 35 on record · 2 in the last 12 months
Whale Activity
Position changes in GMED reported for 2026-06-30 by 12 tracked institutional filers
- Increased4
- New1
- Held0
- Decreased2
- Closed1
- No prior filing4
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 10.8M | $853.8M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.1M | $403.5M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.0M | $394.6M | increased |
| ANCHOR CAPITAL ADVISORS LLC | 648.3K | $51.2M | — |
| Pembroke Management, LTD | 398.9K | $31.5M | — |
| Bridgewater Associates, LP | 352.0K | $27.8M | increased |
| RENAISSANCE TECHNOLOGIES LLC | 196.9K | $15.6M | new |
| Hyperion Capital Advisors LP | 71.5K | $5.6M | — |
| MILLENNIUM MANAGEMENT LLC | 28.8K | $2.3M | decreased |
| D. E. Shaw & Co., Inc. | 8,300 | $656K | decreased |
| Ruane, Cunniff & Goldfarb L.P. | 6,008 | $475K | — |
| Citadel Advisors LLC | 0 | $0 | closed |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by GMED insiders, by quarter · Form 4
Recent Insider Transactions
404 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| TOBIN JAMES RDirector · Director | Sale | −30.0K | $74.58 | $2.2M | Sep 15, 2026 | Form 4 ↗ |
| ZARRILLI STEPHEN TDirector · Director | Sale | −25.0K | $87.04 | $2.2M | Aug 18, 2026 | Form 4 ↗ |
| Davidar David DDirector | Sale | −25.0K | $80.76 | $2.0M | Jun 5, 2026 | Form 4 ↗ |
| Davidar David DDirector | Option exercise | +25.0K | $26.27 | $657K | Jun 5, 2026 | Form 4 ↗ |
| RHOADS ANN DDirector | Option exercise | +25.0K | $26.27 | $657K | Jun 4, 2026 | Form 4 ↗ |
| Huller KellyEVP, GC, Corporate Secretary | Sale | −20.0K | $94.50 | $1.9M | Feb 25, 2026 | Form 4 ↗ |
| Huller KellyEVP, GC, Corporate Secretary | Option exercise | +20.0K | $43.58 | $872K | Feb 25, 2026 | Form 4 ↗ |
| Huller KellyEVP, GC, Corporate Secretary | Sale | −10.0K | $87.67 | $877K | Feb 12, 2026 | Form 4 ↗ |
| Huller KellyEVP, GC, Corporate Secretary | Option exercise | +10.0K | $45.64 | $456K | Feb 12, 2026 | Form 4 ↗ |
| Kline KyleSenior Vice President, CFO | Sale | −3,594 | $101.10 | $363K | Jan 8, 2026 | Form 4 ↗ |
| Kline KyleSenior Vice President, CFO | Option exercise | +3,594 | $51.87 | $186K | Jan 8, 2026 | Form 4 ↗ |
| Norwalk Leslie VDirector | Sale | −2,000 | $101.10 | $202K | Jan 8, 2026 | Form 4 ↗ |
| Norwalk Leslie VDirector | Sale | −4,000 | $88.85 | $355K | Dec 12, 2025 | Form 4 ↗ |
| Paul David CExecutive Chairman · Director · 10% owner | Option exercise | +34.4K | $25.52 | $877K | Dec 8, 2025 | Form 4 ↗ |
| Kline KyleSenior Vice President, CFO | Sale | −18.5K | $90.00 | $1.7M | Dec 1, 2025 | Form 4 ↗ |
| Kline KyleSenior Vice President, CFO | Option exercise | +4,896 | $63.68 | $312K | Dec 1, 2025 | Form 4 ↗ |
| Kline KyleSenior Vice President, CFO | Option exercise | +5,000 | $64.44 | $322K | Dec 1, 2025 | Form 4 ↗ |
| Kline KyleSenior Vice President, CFO | Option exercise | +5,000 | $56.43 | $282K | Dec 1, 2025 | Form 4 ↗ |
| Kline KyleSenior Vice President, CFO | Option exercise | +3,646 | $53.14 | $194K | Dec 1, 2025 | Form 4 ↗ |
| Huller KellySVP, GC, Corporate Secretary | Sale | −7,500 | $90.00 | $675K | Nov 25, 2025 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding GMED · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF iShares Trust | 3.9M | $306.4M | 0.25% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3.6M | $284.1M | 0.01% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 2.6M | $205.3M | 0.11% | Jun 30, 2026 |
| Janus Henderson Enterprise Fund Janus Investment Fund | 2.2M | $174.4M | 0.78% | Jun 30, 2026 |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 1.5M | $118.2M | 0.25% | Jun 30, 2026 |
| JPMorgan Mid Cap Value Fund J.P. Morgan Fleming Mutual Fund Group, Inc. | 1.5M | $116.6M | 1.04% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.3M | $102.7M | 0.11% | Jun 30, 2026 |
| Allspring Special Mid Cap Value Fund ALLSPRING FUNDS TRUST | 1.2M | $97.5M | 0.72% | Jun 30, 2026 |
| Janus Henderson Triton Fund Janus Investment Fund | 1.1M | $87.8M | 1.48% | Jun 30, 2026 |
| Disciplined Value Mid Cap Fund John Hancock Funds III | 1.0M | $81.4M | 0.35% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list GMED's shares (CUSIP 379577208), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming globus medical as client
Government Contracts
Federal awards to globus medical · USAspending
$17KAwarded · 1 contract on record
- Department of Defense4572525148!INDEPENDENCE MIS SPACER 26 X 34MM 8, 13M$17K
May 28, 2026 · ↗
U.S. Patents
Recent USPTO applications naming GLOBUS MEDICAL INC
No USPTO patent applications found for GLOBUS MEDICAL INC.
Annual Financials
From GMED's 10-K filings · XBRL
No annual XBRL figures on record for GMED. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in GMED's price history.
About GLOBUS MEDICAL INC
From SEC EDGAR company records
Industry (SIC 3841)Surgical & Medical Instruments & Apparatus
SectorHealthcare
HeadquartersAUDUBON, PA
IncorporatedDE
SEC CIK0001237831 ↗